Literature DB >> 16808777

Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers.

Michael D Stein1, Bradley J Anderson, Raymond Niaura.   

Abstract

AIM: To determine the association between daily smoking and use of nicotine replacement therapy (NRT), and to determine predictors of greater NRT use among methadone-maintained smokers. INTERVENTION: Assignment to free nicotine patch (8 to 12 weeks) plus either (1) a baseline-tailored brief motivational intervention, a quit date behavioral skills counseling session, and a relapse prevention follow-up session (max), or (2) brief advice using NCI's 4 A's model (min).
SETTING: Five methadone maintenance treatment centers. PARTICIPANTS: Of the 383 methadone-maintained smokers enrolled, 309 (80.6%) set a specific quit date (received NRT) and were located for assessments. Participants were 51.8% male, 78.6% Caucasian, and smoked 26.6 (SD=12.2) cigarettes/day. OUTCOME: Use of NRT and smoking behaviors during the 180-day follow-up period assessed by the Timeline follow-back method.
FINDINGS: On the day following their quit day, 86.4% of participants used NRT. The percentage of participants using NRT was 52.3%, 27.1%, and 10.4% on day 30, day 60, and day 90, respectively. Participants used NRT on 44.1% of the days through the 90 days of the treatment protocol. The estimated odds of smoking abstinence was 7.1 (P<.001) times higher on days when NRT was used than on days when NRT was not used, and cigarettes/day was also significantly lower on NRT days (14.93 vs 4.65; P<.001).
CONCLUSION: Nicotine replacement therapy use was inconsistent following an initial quit attempt among methadone-maintained smokers. On days when NRT was used, individuals were likely to smoke at reduced levels or not at all.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16808777      PMCID: PMC1924690          DOI: 10.1111/j.1525-1497.2006.00504.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  25 in total

1.  Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users.

Authors:  C T Orleans; N Resch; E Noll; M K Keintz; B K Rimer; T V Brown; T M Snedden
Journal:  JAMA       Date:  1994-02-23       Impact factor: 56.272

2.  Predicting smoking cessation. Who will quit with and without the nicotine patch.

Authors:  S L Kenford; M C Fiore; D E Jorenby; S S Smith; D Wetter; T B Baker
Journal:  JAMA       Date:  1994-02-23       Impact factor: 56.272

3.  Characteristics and perceptions of nicotine patch users.

Authors:  D Haxby; A Sinclair; M P Eiff; M H McQueen; W L Toffler
Journal:  J Fam Pract       Date:  1994-05       Impact factor: 0.493

4.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

5.  The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation.

Authors:  L Biener; D B Abrams
Journal:  Health Psychol       Date:  1991       Impact factor: 4.267

6.  Smoking cessation in methadone maintenance.

Authors:  Steve Shoptaw; Erin Rotheram-Fuller; Xiaowei Yang; Dominick Frosch; Debbie Nahom; Murray E Jarvik; Richard A Rawson; Walter Ling
Journal:  Addiction       Date:  2002-10       Impact factor: 6.526

Review 7.  Tobacco dependence and the nicotine patch. Clinical guidelines for effective use.

Authors:  M C Fiore; D E Jorenby; T B Baker; S L Kenford
Journal:  JAMA       Date:  1992-11-18       Impact factor: 56.272

8.  Tobacco use as a distal predictor of mortality among long-term narcotics addicts.

Authors:  Y I Hser; W J McCarthy; M D Anglin
Journal:  Prev Med       Date:  1994-01       Impact factor: 4.018

9.  Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation.

Authors:  John P Pierce; Elizabeth A Gilpin
Journal:  JAMA       Date:  2002-09-11       Impact factor: 56.272

10.  Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice.

Authors:  J A Stapleton; M A Russell; C Feyerabend; S M Wiseman; G Gustavsson; U Sawe; D Wiseman
Journal:  Addiction       Date:  1995-01       Impact factor: 6.526

View more
  19 in total

1.  Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care.

Authors:  Gareth J Hollands; Stephen Sutton; Máirtín S McDermott; Theresa M Marteau; Paul Aveyard
Journal:  Nicotine Tob Res       Date:  2013-02-19       Impact factor: 4.244

Review 2.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

3.  Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders.

Authors:  Cara M Murphy; James MacKillop; Rosemarie A Martin; Jennifer W Tidey; Suzanne M Colby; Damaris J Rohsenow
Journal:  Psychopharmacology (Berl)       Date:  2017-05-13       Impact factor: 4.530

Review 4.  Consideration of sex in clinical trials of transdermal nicotine patch: a systematic review.

Authors:  Andrea H Weinberger; Philip H Smith; Mira Kaufman; Sherry A McKee
Journal:  Exp Clin Psychopharmacol       Date:  2014-08-18       Impact factor: 3.157

5.  Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Stacey C Sigmon
Journal:  Exp Clin Psychopharmacol       Date:  2011-02       Impact factor: 3.157

Review 6.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

7.  The Untreated Addiction: Going Tobacco-Free in a VA Substance Abuse Residential Rehabilitation Treatment Program (SARRTP).

Authors:  Megan Conrad; Teri Bolte; Leigh Gaines; Zackery Avery; Linda Bodie
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

Review 8.  Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?

Authors:  Nancy Amodei; R J Lamb
Journal:  Psychol Addict Behav       Date:  2008-12

9.  Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.

Authors:  Shadi Nahvi; Bryan Wu; Kimber P Richter; Steven L Bernstein; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2013-01-17       Impact factor: 4.492

Review 10.  Review: the need for smoking cessation among HIV-positive smokers.

Authors:  Shadi Nahvi; Nina A Cooperman
Journal:  AIDS Educ Prev       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.